Resmed Inc (RMD) has declared a quarterly dividend of $0.60 per share, reinforcing its commitment to returning value to shareholders. The dividend will be payable to shareholders of record on December 17, 2025, with an ex-dividend date set for November 12, 2025.
With a current dividend yield of 0.95%, this announcement underscores the company's ongoing strategy to provide regular income to its investors. Resmed, headquartered in San Diego, California, specializes in digital health and cloud-connected medical devices aimed at improving the quality of life for patients with respiratory disorders. The company operates within the Health Care industry and currently boasts a market capitalization of $36.3 billion.
Investors are reminded that to qualify for the upcoming dividend, they must own shares before the ex-dividend date. Resmed's consistent dividend payments reflect its solid financial health, supported by a P/E ratio of 25.21 and an EPS of 9.77. As the company continues to address the needs of patients with chronic diseases, its dividend policy remains an attractive feature for income-focused investors.
Looking ahead, Resmed is scheduled to report its next earnings on July 28, 2026, with an estimated EPS of $2.87 and revenue expectations of $1.5 billion. Such financial metrics will be crucial for assessing the sustainability of its dividend strategy in the future.